[NRIX] QoQ Quarter Result on 30-Nov-2019 [#Q4]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
29-Nov-2019
Financial Year
2019
Quarter
30-Nov-2019 [#Q4]
Profit Trend
QoQ- -457.03%
YoY-
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
31/08/20 31/05/20 29/02/20 30/11/19 31/08/19 31/05/19 28/02/19 CAGR
Revenue 4,085 4,182 2,864 1,862 10,580 9,439 9,234 -41.79%
PBT -18,517 -13,007 -12,380 -13,309 -2,417 -3,058 -2,676 261.00%
Tax -675 -20,587 11 210 10 10 9 -
NP -18,517 7,580 -12,391 -13,519 -2,427 -3,068 -2,685 260.19%
Tax Rate - - - - - - - -
Total Cost 22,602 -3,398 15,255 15,381 13,007 12,507 11,919 52.90%
Ratio Analysis
31/08/20 31/05/20 29/02/20 30/11/19 31/08/19 31/05/19 28/02/19 CAGR
NP Margin -453.29 181.25 -432.65 -726.05 -22.94 -32.50 -29.08 518.83%
Per Share
31/08/20 31/05/20 29/02/20 30/11/19 31/08/19 31/05/19 28/02/19 CAGR
EPS -1.09 0.22 -0.60 -0.65 -0.12 -0.94 -0.85 17.94%
EPS Diluted -1.09 0.22 -0.60 -0.65 -0.12 -0.94 -0.85 17.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.